ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/11/19 | 2,074 | 2,100 | 2,064 | 2,097 | +18 | +0.9% | 72,100 |
2018/11/16 | 2,087 | 2,094 | 2,062 | 2,079 | -10 | -0.5% | 99,400 |
2018/11/15 | 2,070 | 2,092 | 2,064 | 2,089 | +19 | +0.9% | 49,800 |
2018/11/14 | 2,062 | 2,089 | 2,058 | 2,070 | +8 | +0.4% | 86,800 |
2018/11/13 | 2,074 | 2,079 | 2,050 | 2,062 | -42 | -2% | 87,500 |
2018/11/12 | 2,090 | 2,121 | 2,083 | 2,104 | +11 | +0.5% | 61,700 |
2018/11/09 | 2,074 | 2,112 | 2,074 | 2,093 | +19 | +0.9% | 80,000 |
2018/11/08 | 2,057 | 2,079 | 2,041 | 2,074 | +47 | +2.3% | 56,900 |
2018/11/07 | 2,030 | 2,061 | 2,017 | 2,027 | +2 | +0.1% | 93,000 |
2018/11/06 | 2,030 | 2,034 | 2,001 | 2,025 | +20 | +1% | 140,200 |
2018/11/05 | 2,030 | 2,033 | 1,926 | 2,005 | -110 | -5.2% | 482,300 |
2018/11/02 | 2,078 | 2,126 | 2,078 | 2,115 | +37 | +1.8% | 130,200 |
2018/11/01 | 2,096 | 2,112 | 2,072 | 2,078 | -33 | -1.6% | 74,700 |
2018/10/31 | 2,060 | 2,120 | 2,046 | 2,111 | +38 | +1.8% | 111,900 |
2018/10/30 | 2,012 | 2,073 | 2,009 | 2,073 | +61 | +3% | 317,300 |
2018/10/29 | 2,049 | 2,062 | 2,012 | 2,012 | -24 | -1.2% | 75,700 |
2018/10/26 | 2,090 | 2,092 | 2,025 | 2,036 | -33 | -1.6% | 97,500 |
2018/10/25 | 2,142 | 2,142 | 2,064 | 2,069 | -111 | -5.1% | 89,000 |
2018/10/24 | 2,206 | 2,233 | 2,170 | 2,180 | -10 | -0.5% | 87,200 |
2018/10/23 | 2,263 | 2,263 | 2,187 | 2,190 | -91 | -4% | 114,900 |
2018/10/22 | 2,259 | 2,298 | 2,232 | 2,281 | +23 | +1% | 85,300 |
2018/10/19 | 2,265 | 2,265 | 2,237 | 2,258 | -3 | -0.1% | 62,200 |
2018/10/18 | 2,273 | 2,280 | 2,255 | 2,261 | +6 | +0.3% | 99,700 |
2018/10/17 | 2,233 | 2,262 | 2,227 | 2,255 | +40 | +1.8% | 103,600 |
2018/10/16 | 2,173 | 2,215 | 2,161 | 2,215 | +40 | +1.8% | 119,100 |
2018/10/15 | 2,195 | 2,198 | 2,163 | 2,175 | -48 | -2.2% | 136,800 |
2018/10/12 | 2,282 | 2,291 | 2,221 | 2,223 | -52 | -2.3% | 124,900 |
2018/10/11 | 2,280 | 2,295 | 2,252 | 2,275 | -39 | -1.7% | 125,700 |
2018/10/10 | 2,290 | 2,328 | 2,270 | 2,314 | +23 | +1% | 105,400 |
2018/10/09 | 2,321 | 2,332 | 2,274 | 2,291 | -63 | -2.7% | 160,900 |
2018/10/05 | 2,367 | 2,377 | 2,343 | 2,354 | -40 | -1.7% | 75,200 |
2018/10/04 | 2,441 | 2,441 | 2,365 | 2,394 | -47 | -1.9% | 76,400 |
2018/10/03 | 2,489 | 2,497 | 2,441 | 2,441 | -48 | -1.9% | 73,300 |
2018/10/02 | 2,462 | 2,499 | 2,460 | 2,489 | +16 | +0.6% | 74,600 |
2018/10/01 | 2,493 | 2,505 | 2,466 | 2,473 | -41 | -1.6% | 56,800 |
2018/09/28 | 2,500 | 2,540 | 2,473 | 2,514 | +20 | +0.8% | 93,300 |
2018/09/27 | 2,519 | 2,541 | 2,483 | 2,494 | -50 | -2% | 82,900 |
2018/09/26 | 2,513 | 2,548 | 2,508 | 2,544 | -12 | -0.5% | 101,100 |
2018/09/25 | 2,452 | 2,558 | 2,450 | 2,556 | +129 | +5.3% | 233,200 |
2018/09/21 | 2,440 | 2,441 | 2,407 | 2,427 | +8 | +0.3% | 109,900 |
2018/09/20 | 2,462 | 2,462 | 2,405 | 2,419 | -37 | -1.5% | 81,400 |
2018/09/19 | 2,420 | 2,470 | 2,409 | 2,456 | +51 | +2.1% | 102,400 |
2018/09/18 | 2,372 | 2,410 | 2,341 | 2,405 | +23 | +1% | 74,300 |
2018/09/14 | 2,378 | 2,404 | 2,369 | 2,382 | +25 | +1.1% | 102,000 |
2018/09/13 | 2,336 | 2,384 | 2,335 | 2,357 | +28 | +1.2% | 43,700 |
2018/09/12 | 2,349 | 2,349 | 2,297 | 2,329 | -23 | -1% | 64,900 |
2018/09/11 | 2,344 | 2,356 | 2,326 | 2,352 | +9 | +0.4% | 45,500 |
2018/09/10 | 2,357 | 2,390 | 2,337 | 2,343 | -16 | -0.7% | 44,600 |
2018/09/07 | 2,358 | 2,379 | 2,335 | 2,359 | +1 | ±0% | 45,900 |
2018/09/06 | 2,376 | 2,376 | 2,348 | 2,358 | -19 | -0.8% | 40,100 |
1651~
1700
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 203,600円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 264,500円 | +21.7% | +999.9% | 0.00% | 12.19倍 | 4.17倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 314,500円 | +5.1% | -7.0% | 2.54% | 20.65倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
栄研化 | 247,000円 | +4.1% | -3.1% | 2.35% | 21.46倍 | 1.87倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
杏林製薬 | 152,000円 | -2.4% | -52.3% | 3.75% | 18.19倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム